Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Sette

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Journal of Leukocyte Biology|June 6, 2007
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compoundMaria Loiarro, Federica Capolunghi, Nicola Fantò, et al.
Protein Science : a Publication of the Protein Society|January 20, 2026
Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatmentAnnalisa Pia Abbinantefina, Claudia Tito, Silvia Masciarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder CancerPamela Bielli, Valentina Panzeri, Rossano Lattanzio, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2023
MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastomaConsuelo Pitolli, Alberto Marini, Marika Guerra, et al.
Developmental Cell|April 4, 2017
An Orchestrated Intron Retention Program in Meiosis Controls Timely Usage of Transcripts during Germ Cell DifferentiationChiara Naro, Ariane Jolly, Sara Di Persio, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Human Molecular Genetics|May 28, 2004
SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasomeJulian P Venables, Caroline Dalgliesh, Maria Paolo Paronetto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell typesRoberta Galli, Donatella Starace, Roberta Busà, et al.
International Journal of Colorectal Disease|May 11, 2004
Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patientsInnocenzo Sammarco, Gabriele Capurso, Luigi Coppola, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2025
Epigenetic modulation of RIPK3 by transglutaminase 2-dependent serotonylation of H3K4me3 affects necroptosisAlessio Vecchio, Fiorella Colasuonno, Luca Occhigrossi, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Journal of Leukocyte Biology|June 6, 2007
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compoundMaria Loiarro, Federica Capolunghi, Nicola Fantò, et al.
Protein Science : a Publication of the Protein Society|January 20, 2026
Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatmentAnnalisa Pia Abbinantefina, Claudia Tito, Silvia Masciarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder CancerPamela Bielli, Valentina Panzeri, Rossano Lattanzio, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2023
MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastomaConsuelo Pitolli, Alberto Marini, Marika Guerra, et al.
Developmental Cell|April 4, 2017
An Orchestrated Intron Retention Program in Meiosis Controls Timely Usage of Transcripts during Germ Cell DifferentiationChiara Naro, Ariane Jolly, Sara Di Persio, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Human Molecular Genetics|May 28, 2004
SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasomeJulian P Venables, Caroline Dalgliesh, Maria Paolo Paronetto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell typesRoberta Galli, Donatella Starace, Roberta Busà, et al.
International Journal of Colorectal Disease|May 11, 2004
Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patientsInnocenzo Sammarco, Gabriele Capurso, Luigi Coppola, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2025
Epigenetic modulation of RIPK3 by transglutaminase 2-dependent serotonylation of H3K4me3 affects necroptosisAlessio Vecchio, Fiorella Colasuonno, Luca Occhigrossi, et al.
Pageof 18